EGFR and neoplasm: An example of a receptor that has been successfully ablated using LYTACs is the epidermal growth factor receptor (EGFR).4,5 EGFR plays a pivotal role in tumour growth, survival, and resistance mechanisms, making it a high-value target in multiple cancer types.6